Skip to main content
KNSA $93.90 +0.38%
KNSA logo
KNSA · Kiniksa Pharmaceuticals International, plc
Track KNSA — free
$93.90 +0.36 (+0.38%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$7.38B
Shares
78.57M
Volume · Nov 20 545.23K Avg daily vol (3M) 658.72K
All webcasts

Earnings call · FY2026 Q1

Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call

Concluded Apr 28, 2026
Apr 28, 2026
Period
FY2026 Q1
Runtime
—
Sources
2 artifacts
Revenue $214.27M +55.5% YoY
Diluted EPS $0.27 +145.5% YoY
Gross margin · derived Q4 90.3% +3.3 pp YoY
Net income $22.59M +164.6% YoY
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document